Profile data is unavailable for this security.
About the company
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
- Revenue in JPY (TTM)3.35tn
- Net income in JPY30.44bn
- Incorporated1923
- Employees12.80k
- LocationMedipal Holdings Corp2-7-15, YaesuCHUO-KU 104-8461JapanJPN
- Phone+81 335175800
- Fax+81 335175028
- Websitehttps://www.medipal.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 7459:TYO since announced | Transaction value |
|---|---|---|
| Sumitomo Pharma Food & Chemical Co Ltd | -2.17% | 313.47m |
| Toshichi Inc | -12.17% | 56.26m |
Data delayed at least 20 minutes, as of Mar 31 2023 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Herbalife Nutrition Ltd | 690.39bn | 42.62bn | 206.68bn | 10.10k | 4.89 | -- | 3.57 | 0.2994 | 3.22 | 3.22 | 52.29 | -12.93 | 1.87 | 2.03 | 75.70 | 515,287.10 | 11.57 | 12.33 | 18.39 | 20.63 | 77.45 | 79.33 | 6.17 | 6.64 | 0.794 | 4.35 | 1.89 | 0.00 | -10.31 | 3.29 | -28.15 | -2.64 | 10.37 | -- |
| Nu Skin Enterprises, Inc. | 295.24bn | 13.90bn | 257.20bn | 3.80k | 18.87 | 2.16 | 10.90 | 0.8711 | 2.08 | 2.08 | 44.10 | 18.13 | 1.19 | 1.69 | 50.21 | 585,699.80 | 5.62 | 8.18 | 7.38 | 10.93 | 71.65 | 74.77 | 4.71 | 5.86 | 1.15 | -- | 0.3097 | 53.39 | -17.44 | -0.4734 | -28.85 | -9.97 | -0.3684 | 1.35 |
| Tibet Rhodiola Pharmaceutical Holding Co | 49.31bn | 7.14bn | 257.98bn | 615.00 | 36.14 | 4.44 | -- | 5.23 | 1.49 | 1.49 | 10.30 | 12.15 | 0.6466 | 1.51 | 5.56 | 4,153,836.00 | 9.50 | 10.12 | 13.09 | 12.31 | 92.98 | 87.54 | 14.69 | 18.50 | 2.55 | 41.64 | 0.1387 | 42.59 | 19.45 | 22.78 | 76.99 | 10.00 | -30.03 | 7.81 |
| Suzuken Co Ltd | 2.31tn | 19.31bn | 289.96bn | 14.03k | 14.84 | 0.661 | 10.57 | 0.1257 | 221.97 | 221.97 | 26,413.14 | 4,985.06 | 1.78 | 13.04 | 4.05 | 164,380,000.00 | 1.49 | 1.75 | 4.36 | 4.59 | 7.74 | 8.21 | 0.836 | 0.9239 | 1.00 | -- | 0.00 | 31.84 | 4.91 | 0.9754 | 82.31 | -7.55 | 2.14 | 5.92 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 20.86bn | -4.93bn | 335.82bn | 1.90k | -- | 8.49 | -- | 16.10 | -0.5216 | -0.5216 | 2.21 | 4.19 | 0.3414 | 1.17 | 0.8856 | 568,822.60 | -8.47 | 3.08 | -11.64 | 4.32 | 60.07 | 75.75 | -24.81 | 8.02 | 2.37 | -9.71 | 0.2265 | 11.21 | -23.00 | -1.83 | -1,088.17 | -- | -36.34 | -- |
| Alfresa Holdings Corporation | 2.67tn | 28.25bn | 341.18bn | 11.93k | 12.11 | 0.7068 | 8.20 | 0.1279 | 138.85 | 138.85 | 13,147.11 | 2,379.80 | 1.89 | 14.87 | 4.05 | 223,746,900.00 | 2.00 | 2.63 | 5.54 | 7.04 | 7.24 | 7.40 | 1.06 | 1.33 | 1.03 | -- | 0.00002 | 29.60 | -0.9494 | 0.2638 | 31.35 | 0.8209 | 4.54 | 8.45 |
| China Medicine Health Industry Co Ltd | 703.12bn | 11.16bn | 393.01bn | 8.72k | 35.21 | 1.88 | -- | 0.5590 | 0.3865 | 0.3865 | 24.35 | 7.24 | 1.11 | 5.15 | 2.77 | 4,179,414.00 | 1.94 | 5.00 | 4.02 | 11.55 | 13.24 | 16.44 | 1.76 | 3.93 | 1.28 | 6.79 | 0.3125 | 37.30 | -7.83 | 6.91 | -50.63 | -7.39 | 12.03 | -0.9072 |
| Medipal Holdings Corp | 3.35tn | 30.44bn | 402.45bn | 12.80k | 12.77 | 0.6771 | 7.43 | 0.1201 | 139.74 | 139.74 | 15,258.57 | 2,636.25 | 1.87 | 16.61 | 4.34 | 261,781,800.00 | 2.21 | 2.60 | 6.66 | 7.26 | 6.67 | 7.02 | 1.18 | 1.32 | 1.03 | -- | 0.0424 | 26.65 | 2.48 | 1.44 | 22.98 | 0.2824 | -12.03 | 7.26 |
| Fah Mai Holdings Group Inc | 10.90m | -58.65m | 517.35bn | -- | -- | -- | -- | 47,479.92 | -0.4413 | -0.4413 | 0.082 | 304.06 | 0.0003 | 10.29 | 53.17 | -- | -0.175 | -- | -0.1752 | -- | 62.47 | -- | -538.28 | -- | 0.0079 | -- | 0.3963 | -- | 6.82 | -- | -93.99 | -- | -- | -- |
| China Medical System Holdings | 176.27bn | 62.78bn | 519.61bn | 5.45k | 8.28 | 1.85 | 7.70 | 2.95 | 1.51 | 1.51 | 4.25 | 6.78 | 0.5453 | 4.45 | 5.32 | -- | 19.52 | 19.73 | 23.10 | 22.24 | 76.89 | 74.79 | 35.80 | 35.22 | 2.90 | -- | 0.1095 | 39.88 | 9.75 | 11.34 | 8.01 | 14.24 | -- | 14.80 |
| China National Medicines Corp Ltd | 878.30bn | 37.91bn | 522.01bn | 3.08k | 13.77 | 1.90 | -- | 0.5943 | 2.60 | 2.60 | 60.30 | 18.84 | 1.58 | 11.56 | 7.94 | 14,772,270.00 | 7.39 | 7.32 | 14.72 | 15.58 | 8.15 | 8.30 | 4.68 | 4.19 | 1.73 | -- | 0.1617 | 28.61 | -2.09 | 4.63 | 11.97 | 11.46 | 12.12 | 11.69 |
| Jointown Pharmaceutical Group Co Ltd | 2.57tn | 35.10bn | 543.32bn | 29.34k | 15.66 | 1.26 | -- | 0.2112 | 0.959 | 0.959 | 67.90 | 12.94 | 1.48 | 8.76 | 3.67 | 4,542,242.00 | 2.22 | 3.19 | 7.21 | 9.83 | 7.48 | 8.53 | 1.50 | 2.15 | 1.03 | 3.41 | 0.593 | 41.35 | 10.42 | 14.74 | -17.76 | 24.34 | 3.80 | -- |
Data as of Mar 31 2023. Currency figures normalised to Medipal Holdings Corp's reporting currency: Japanese Yen JPY
21.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 10 Jan 2023 | 24.99m | 10.22% |
| Nomura Asset Management Co., Ltd.as of 30 Sep 2022 | 7.37m | 3.01% |
| The Vanguard Group, Inc.as of 03 Mar 2023 | 3.75m | 1.54% |
| Norges Bank Investment Managementas of 31 Dec 2022 | 3.38m | 1.38% |
| Nikko Asset Management Co., Ltd.as of 03 Mar 2023 | 3.21m | 1.31% |
| Daiwa Asset Management Co. Ltd.as of 28 Feb 2023 | 3.18m | 1.30% |
| BlackRock Fund Advisorsas of 01 Mar 2023 | 2.11m | 0.86% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 02 Mar 2023 | 1.63m | 0.67% |
| Geode Capital Management LLCas of 31 Jan 2023 | 1.55m | 0.63% |
| Dimensional Fund Advisors LPas of 02 Mar 2023 | 1.36m | 0.56% |
More ▼
Data from 31 Dec 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
